Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-057967

Chief Legal Officer sold 8,690 shares at $3.57 ($31,023)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew Chief Legal Officer 2022-11-16 Sale −8,690 $3.57 $31,023 272,498 D
Open-market sales · 8,690 sh · avg $3.57 · $31,023
Loading xslF345X03/doc4.xml…